Schmidt-Wolf IG - Search Results

1

Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.

Lu D, Liu JX, Endo T, Zhou H, Yao S, Willert K, Schmidt-Wolf IG, Kipps TJ, Carson DA. Lu D, et al. PLoS One. 2009 Dec 14;4(12):e8294. doi: 10.1371/journal.pone.0008294. PLoS One. 2009. PMID: 20011538 Free PMC article.

2

Influencing the Wnt signaling pathway in multiple myeloma.

Kim Y, Reifenberger G, Lu D, Endo T, Carson DA, Gast SM, Meschenmoser K, Nowak M, Schmidt-Wolf IG. Kim Y, et al. Anticancer Res. 2011 Feb;31(2):725-30. Anticancer Res. 2011. PMID: 21378363 Review.

3

Increased in vivo efficacy of lenalidomide and thalidomide by addition of ethacrynic acid.

Schmidt M, Kim Y, Gast SM, Endo T, Lu D, Carson D, Schmidt-Wolf IG. Schmidt M, et al. In Vivo. 2011 May-Jun;25(3):325-33. In Vivo. 2011. PMID: 21576405

4

Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.

Kim Y, Schmidt M, Endo T, Lu D, Carson D, Schmidt-Wolf IG. Kim Y, et al. In Vivo. 2011 Nov-Dec;25(6):887-93. In Vivo. 2011. PMID: 22021681

5

In vivo efficacy of the diuretic agent ethacrynic acid against multiple myeloma.

Kim Y, Gast SM, Endo T, Lu D, Carson D, Schmidt-Wolf IG. Kim Y, et al. Leuk Res. 2012 May;36(5):598-600. doi: 10.1016/j.leukres.2012.01.025. Epub 2012 Mar 2. Leuk Res. 2012. PMID: 22386728

6

Targeting the Wnt/beta-catenin pathway in multiple myeloma.

Schmeel LC, Schmeel FC, Kim Y, Endo T, Lu D, Schmidt-Wolf IG. Schmeel LC, et al. Anticancer Res. 2013 Nov;33(11):4719-26. Anticancer Res. 2013. PMID: 24222106

7

Targeting Wnt pathway in lymphoma and myeloma cells.

Schmidt M, Sievers E, Endo T, Lu D, Carson D, Schmidt-Wolf IG. Schmidt M, et al. Br J Haematol. 2009 Mar;144(5):796-8. doi: 10.1111/j.1365-2141.2008.07503.x. Epub 2008 Nov 20. Br J Haematol. 2009. PMID: 19036118 Free article. No abstract available.

8

In vivo efficacy of griseofulvin against multiple myeloma.

Kim Y, Alpmann P, Blaum-Feder S, Krämer S, Endo T, Lu D, Carson D, Schmidt-Wolf IG. Kim Y, et al. Leuk Res. 2011 Aug;35(8):1070-3. doi: 10.1016/j.leukres.2010.10.008. Epub 2010 Nov 26. Leuk Res. 2011. PMID: 21112630

9

Increased in vivo efficacy of lenalidomide by addition of piroctone olamine.

Kim Y, Alpmann P, Blaum-Feder S, Krämer S, Endo T, Lu D, Carson D, Schmidt-Wolf IG. Kim Y, et al. In Vivo. 2011 Jan-Feb;25(1):99-103. In Vivo. 2011. PMID: 21282741

10

Flunarizine exhibits in vitro efficacy against lymphoma and multiple myeloma cells.

Schmeel LC, Schmeel FC, Kim Y, Blaum-Feder S, Endo T, Schmidt-Wolf IG. Schmeel LC, et al. Anticancer Res. 2015 Mar;35(3):1369-76. Anticancer Res. 2015. PMID: 25750287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters